Nuveen, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Nuveen, LLC holds 518,543 shares of RARE stock, worth $20.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
518,543Holding current value
$20.2 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
343Shares Held
85.2MCall Options Held
659KPut Options Held
829K-
Vanguard Group Inc Valley Forge, PA10MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$218 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$167 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$106 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.72B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...